CLINICAL TOXICOLOGY is a prestigious journal dedicated to advancing the field of toxicology, published by Taylor & Francis Ltd. With ISSN 1556-3650 and E-ISSN 1556-9519, it has been a vital resource for researchers, clinicians, and students since its inception in 1968. The journal is recognized for its high impact, boasting a Q1 quartile ranking in both the categories of Medicine (miscellaneous) and Toxicology as of 2023, reflecting its reputation for disseminating significant contributions to the field. CLINICAL TOXICOLOGY primarily features original research, reviews, and case reports that explore the latest advancements and methodologies in the diagnosis and management of toxic exposures, making it an essential tool for professionals seeking to stay abreast of current trends and best practices. The journal's open access options ensure that its content is readily available to a wide audience, thereby promoting the exchange of knowledge and collaborative efforts within the global scientific community. For those committed to improving public health outcomes through toxicological research, CLINICAL TOXICOLOGY provides an indispensable platform for publication and discourse.

Toxicology Communications is a vital academic journal published by Taylor & Francis Ltd, focusing on the critical field of toxicology. Established as an Open Access journal since 2017, it provides researchers, professionals, and students unrestricted access to significant findings in toxicological sciences, promoting global collaboration and knowledge sharing. The journal aims to disseminate innovative research, reviews, and case studies that explore the effects of chemical, biological, and physical agents on human health and the environment. With its commitment to high-quality publications, Toxicology Communications plays an essential role in advancing our understanding of toxicological phenomena and fostering safe practices across various industries. This makes it an invaluable resource for anyone dedicated to the studies of toxins and their environmental and health implications.

European Journal of Therapeutics is a distinguished journal dedicated to advancing the field of therapeutic sciences through high-quality research and innovative clinical practice. Published by Pera Yayincilik Hizmetleri, this interdisciplinary journal aims to facilitate knowledge dissemination in areas such as pharmacology, clinical medicine, and public health, thereby supporting both researchers and practitioners in improving therapeutic outcomes. Although the journal operates under a subscription model, its commitment to rigorous peer review ensures that published articles reflect the latest advancements and methodologies. With a growing emphasis on evidence-based therapies, the European Journal of Therapeutics serves as a vital platform for dialogue among healthcare professionals and researchers, enhancing the understanding of therapeutic interventions on a global scale. It welcomes contributions ranging from original research to review articles, making it an essential resource for those seeking to enrich their knowledge and influence practice in therapeutic approaches.

CELL BIOLOGY AND TOXICOLOGY, published by SPRINGER, stands as a vital journal within the realms of cell biology and toxicology, boasting an impressive 2023 Q1 ranking in its fields, alongside robust Scopus rankings placing it in the top 11th percentile for Toxicology and the 22nd for Health, Toxicology and Mutagenesis. With an ISSN of 0742-2091 and an E-ISSN of 1573-6822, the journal has been a cornerstone of scientific discourse since its inception in 1984, and will continue to converge innovative research until 2024. The journal focuses on the interplay between cellular mechanisms and toxicological implications, making it an essential resource for researchers, healthcare professionals, and students keen on advancing their understanding of these critical areas. Although it does not offer open access, its high impact and prestigious standing ensure that its publications reach a wide audience dedicated to significant advancements in the life sciences.

Exposure and Health is a pioneering journal published by Springer, specializing in the interdisciplinary fields of health, toxicology, and environmental sciences. With an ISSN of 2451-9766 and E-ISSN of 2451-9685, this open-access journal exemplifies a commitment to disseminating high-quality research that informs public health practices and policies globally. Situated in the Netherlands, it boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple categories in the 2023 Scopus rankings, including Health, Toxicology and Mutagenesis, Pollution, and Water Science and Technology. The journal is dedicated to advancing knowledge on the interactions between environmental factors and health outcomes, making it a vital resource for researchers, professionals, and students in these critical fields. Exposure and Health actively encourages submissions that address the challenges of exposure assessment, risk management, and the promotion of sustainable public health initiatives.

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.

TOXICOLOGICAL SCIENCES, published by Oxford University Press, is a premier journal in the field of toxicology that has been a cornerstone of scientific discourse since its inception in 1981. With an impressive 2023 impact factor and ranked in the Q1 category for Toxicology, this journal is highly regarded among researchers, professionals, and students dedicated to pharmacology and toxicology. The journal is committed to advancing the understanding of toxicological science, covering a breadth of topics that include the mechanisms of toxicity, risk assessment, and the regulatory aspects affecting public health. With an ISSN of 1096-6080 and an E-ISSN of 1096-0929, TOXICOLOGICAL SCIENCES facilitates open access scholarly work, ensuring that critical research reaches a global audience and promotes collaborative learning. As it converges towards 2024, the journal remains pivotal in shaping the future of toxicology research, providing insights that are essential for developing safer chemicals and protecting environmental health.

Bangladesh Journal of Medical Science, published by IBN SINA TRUST, is a prominent open access journal dedicated to the dissemination of innovative research in the field of medicine. Since its inception in 2009, this journal has aimed to bridge the gap in medical knowledge, focusing on a diverse array of sub-disciplines within the field, thus extending its relevance to both local and international audiences. With an ISSN of 2223-4721 and E-ISSN 2076-0299, it has gained recognition in the academic community, evidenced by its Q3 category rank in Medical (Miscellaneous) and a notable placement in the 58th percentile of general medicine according to Scopus rankings. The journal accepts original research articles, reviews, and case reports, making it a vital resource for researchers, professionals, and students alike. With an objective to provide open access to high-quality medical science literature, the Bangladesh Journal of Medical Science fosters an environment of scholarly exchange, contributing to the ongoing advancement of healthcare practices and medical education in Bangladesh and beyond.

Toxicologie Analytique et Clinique is a distinguished journal published by ELSEVIER MASSON SAS EDITEUR, specializing in the ever-evolving fields of toxicology and clinical analysis. With its ISSN number 2352-0078 and E-ISSN 2352-0086, this journal has been contributing to the scientific dialogue since its inception in 2014, with a converged publication timeline extending to 2024. Despite its current standing in the Q4 category for both Health, Toxicology and Mutagenesis, and Toxicology in the 2023 metrics, as indicated by its rankings on Scopus, Toxicologie Analytique et Clinique remains a crucial platform for disseminating vital research within these domains. The journal's focus on analytical and clinical toxicology makes it an invaluable resource for researchers, practitioners, and students, seeking to enhance their understanding and methodologies in toxicological studies. As a vital contributor to the academic landscape, Toxicologie Analytique et Clinique aims to provide a rich repository of knowledge that promotes innovation and safety in clinical practices and environmental science.

Revista del Cuerpo Medico del Hospital Nacional Almanzor Aguinaga Asenjo is a prominent medical journal published by the renowned Hospital Nacional Almanzor Aguinaga Asenjo in Peru. With the ISSN 2225-5109 and E-ISSN 2227-4731, this open-access journal has been serving the medical community since its inception in 2019. It aims to disseminate vital research and insights in the fields of health and medicine, providing a platform for the exchange of knowledge on critical issues affecting public health and healthcare policy in Latin America. Although classified in the Q4 category for both Health (social science) and Medicine (miscellaneous) in 2023, its essential contributions to health professions and policy add significant value to researchers and practitioners alike. Positioned within the context of a rapidly evolving healthcare landscape, the journal is crucial for fostering a better understanding of the challenges and innovations in healthcare delivery and medical practice. Researchers, professionals, and students looking to deepen their understanding of these fields will find this journal invaluable as it continues to grow and adapt through 2024 and beyond.